| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvants for influenza vaccine
|
Le Cam (xc*), N.N. Bouveret
|
|
1998
|
149 |
1 |
p. 19-23
5 p.
|
article
|
| 2 |
A novel mucosal influenza vaccine
|
Bacon, A.
|
|
1998
|
149 |
1 |
p. 98-
1 p.
|
article
|
| 3 |
An overview of current vaccine development
|
Plotkin, S.
|
|
1998
|
149 |
1 |
p. 11-13
3 p.
|
article
|
| 4 |
Delivery of recombinant adenylate cyclase of Bordetella pertussis carrying a foreign epitope in the MHC class I processing pathway
|
Guermonprez, P.
|
|
1998
|
149 |
1 |
p. 96-
1 p.
|
article
|
| 5 |
Development of a living bacterial carrier system, based on the lipoprotein I of Pseudomonas aeruginosa, for oral vaccination against foot-and-mouth-disease virus
|
Jongert, E.
|
|
1998
|
149 |
1 |
p. 97-
1 p.
|
article
|
| 6 |
Development of stable formulations for PLGA/PLA microsphere vaccines
|
Cleland, J.L.
|
|
1998
|
149 |
1 |
p. 45-47
3 p.
|
article
|
| 7 |
DNA vaccines : immunogenicity, mechanisms, and preclinical efficacy
|
Donnelly, J.J.
|
|
1998
|
149 |
1 |
p. 59-62
4 p.
|
article
|
| 8 |
Elisa and vn antibody responses in serum, upper respiratory tract, lung, genital tract and intestinal tract induced by intranasal and subcutaneous administrations of rsy iscoms
|
Hu, K.-F.
|
|
1998
|
149 |
1 |
p. 91-92
2 p.
|
article
|
| 9 |
Enhanced and prolonged humoral and cell-mediated immune responses to synthetic malarial peptides microencapsulated in biodegradable microspheres
|
Gander, B.
|
|
1998
|
149 |
1 |
p. 92-
1 p.
|
article
|
| 10 |
Experimental mucosal immunization against a widespread bacterial antigen: phosphorylcholine loaded in microspheres protects mice against pneumococcal pneumonia
|
Trollé, S.
|
|
1998
|
149 |
1 |
p. 100-
1 p.
|
article
|
| 11 |
Factors determining antibody isotype in measles virus DNA vaccination
|
Cardoso, I.
|
|
1998
|
149 |
1 |
p. 99-100
2 p.
|
article
|
| 12 |
Immunostimulatory DNA sequences modulate T helper cell response
|
Kobayashi, H.
|
|
1998
|
149 |
1 |
p. 63-65
3 p.
|
article
|
| 13 |
Induction of allograft rejection in tolerant animals by specific T-cell DNA vaccination
|
Vignes, C.
|
|
1998
|
149 |
1 |
p. 95-96
2 p.
|
article
|
| 14 |
Interleukin 12 as vaccine adjuvant
|
Sturmhoefel, K.
|
|
1998
|
149 |
1 |
p. 37-39
3 p.
|
article
|
| 15 |
Intragastric compared to oral administration of BCG induces identical immune responses without side effects
|
Lagranderie, M.
|
|
1998
|
149 |
1 |
p. 100-101
2 p.
|
article
|
| 16 |
Introduction
|
Leclerc, C.
|
|
1998
|
149 |
1 |
p. 9-
1 p.
|
article
|
| 17 |
Lactic acid bacteria in live vaccine development: designing tools to target antigens to a defined cell compartment
|
Piard, J.-C.
|
|
1998
|
149 |
1 |
p. 101-102
2 p.
|
article
|
| 18 |
Live bacterial vectors for intranasal delivery of protective antigens
|
Locht, C.
|
|
1998
|
149 |
1 |
p. 83-85
3 p.
|
article
|
| 19 |
Mucosal adjuvant effect of genetically modified cholera toxin and Escherichia coli heat-labile enterotoxin derivatives
|
De Magistris, M.T.
|
|
1998
|
149 |
1 |
p. 33-35
3 p.
|
article
|
| 20 |
Mycobacterial lipoproteins as vaccine candidates for DNA and subunit vaccines against tuberculosis
|
Vordermeier, M.
|
|
1998
|
149 |
1 |
p. 94-
1 p.
|
article
|
| 21 |
New non-replicative vectors for CTL activation
|
Leclerc, C.
|
|
1998
|
149 |
1 |
p. 67-69
3 p.
|
article
|
| 22 |
New prospects for mucosal immunization: anti-infectious and anti-inflammatory vaccines
|
Holmgren, J.
|
|
1998
|
149 |
1 |
p. 29-31
3 p.
|
article
|
| 23 |
On the potential of retro-inverso peptides in vaccine design
|
Muller, S.
|
|
1998
|
149 |
1 |
p. 55-57
3 p.
|
article
|
| 24 |
P40: a promising new carrier protein
|
Rauly, I.
|
|
1998
|
149 |
1 |
p. 99-
1 p.
|
article
|
| 25 |
Peptide mimicry of carbohydrate structures
|
Phalipon, A.
|
|
1998
|
149 |
1 |
p. 75-77
3 p.
|
article
|
| 26 |
Polymeric systems for vaccine delivery
|
Davis, S.S.
|
|
1998
|
149 |
1 |
p. 49-52
4 p.
|
article
|
| 27 |
RAP-PCR as a means of determining vaccine leads in mycobacteria
|
Bedwell, J.
|
|
1998
|
149 |
1 |
p. 98-99
2 p.
|
article
|
| 28 |
Recent advances with new vaccine adjuvants: from preclinical to clinical development
|
Slaoui, M.
|
|
1998
|
149 |
1 |
p. 15-18
4 p.
|
article
|
| 29 |
Recombinant Mycobacterium bovis BCG producing the N-terminal half of SIV mac251 Env antigen induces neutralizing antibodies and CTL responses in mice and guinea pigs
|
Lim, E.M.
|
|
1998
|
149 |
1 |
p. 101-
1 p.
|
article
|
| 30 |
Recombinant poxvirus vaccine candidates: update and perspectives
|
Tartaglia, J.
|
|
1998
|
149 |
1 |
p. 79-82
4 p.
|
article
|
| 31 |
Recombinant rotavirus outer capsid protein a subunit vaccine
|
Kang, D.K.
|
|
1998
|
149 |
1 |
p. 93-94
2 p.
|
article
|
| 32 |
Recombinant Salmonella as vaccine carriers
|
Kraehenbuhl, J.P.
|
|
1998
|
149 |
1 |
p. 87-90
4 p.
|
article
|
| 33 |
Study of immunogenicity of different molecular structures of orthomyxovirus glycoprotein antigens
|
Berezin, V.E.
|
|
1998
|
149 |
1 |
p. 93-
1 p.
|
article
|
| 34 |
Subunit vaccines produced and delivered in transgenic plants as “edible vaccines”
|
Mason, H.S.
|
|
1998
|
149 |
1 |
p. 71-74
4 p.
|
article
|
| 35 |
Synthesis and antiviral activity of foot-and-mouth disease virus (FMDV) VPI fragments
|
Rybakov, S.S.
|
|
1998
|
149 |
1 |
p. 91-
1 p.
|
article
|
| 36 |
T cells and vaccination
|
Kourilsky, P.
|
|
1998
|
149 |
1 |
p. 41-43
3 p.
|
article
|
| 37 |
The adjuvant MF59: the 1998 perspective, clinical performance and mechanism of action
|
Ott, G.
|
|
1998
|
149 |
1 |
p. 25-27
3 p.
|
article
|
| 38 |
The bordetella pertussis filamentous h˦magglutinin enhances immunogenicity of sm28GST in liposomes
|
Poulain-Godefroy, O.
|
|
1998
|
149 |
1 |
p. 95-
1 p.
|
article
|
| 39 |
The potential of lipid-modified peptides as synthetic vaccines, or for intracellular delivery of functional motifs
|
Gras-Masse, H.
|
|
1998
|
149 |
1 |
p. 53-54
2 p.
|
article
|
| 40 |
Towards a DNA vaccine for bovine tuberculosis
|
Chambers, M.
|
|
1998
|
149 |
1 |
p. 94-95
2 p.
|
article
|
| 41 |
Use of Gram-positive bacteria as vaccine vectors
|
Hruby, D.E.
|
|
1998
|
149 |
1 |
p. 92-93
2 p.
|
article
|
| 42 |
Whole virus influenza vaccine activates dendritic cells and promotes t helper-1 activity, while subunit vaccines stimulate T-cell proliferation
|
Saurwein-Teissl, M.
|
|
1998
|
149 |
1 |
p. 97-
1 p.
|
article
|
Journal description